US$ 23.40
cjc-1295 with ipamorelin review + — Peptide Therapy Online cjc 1295 ipamorelin studies CJC-1295
Description
10.1016/j.jep.2016.11.042 141 ZhangQ

Administration of Interleukin-1 Receptor Antagonist Ameliorates Renal Ischemia-Reperfusion Injury

Nat Genet 2002;32:261-6

On efficacy, a 12-week randomized controlled trial (approximately 300 obese adults) showed subjects receiving 1 mg/day of AOD-9604 lost an average of 2.6 kg , versus 0.8 kg in the placebo group

doi: 10.1016/j.atherosclerosis.2005.03.001 70 TsezouAIliopoulosDMalizosKNSimopoulouT
